Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: Competitive interactions

Neurochemical Research

Volumn 22, Issue 10, 1997, Pages 1281-1289

  Wu, Gusheng ^a   Lu, Zi Hua ^a   Alfinito, Peter ^a   Ledeen, Robert W ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

opioid receptor; Adenylyl cyclase; Calcium influx; Gangliosides; GM1 ganglioside; GM1 regulatory functions; NG108 15 cells; Opioid excitatory effects; Opioid receptor

Indexed keywords

ADENYLATE CYCLASE; OPIATE RECEPTOR;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CALCIUM METABOLISM; CALCIUM TRANSPORT; COMPETITIVE INHIBITION; DRUG RECEPTOR BINDING; ENZYME REGULATION; FACILITATION; GM1 GANGLIOSIDOSIS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; SPINAL GANGLION;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; AMINOPTERIN; BINDING, COMPETITIVE; CALCIUM CHANNELS; CHOLERA TOXIN; CYCLIC AMP; ENKEPHALIN, LEUCINE-2-ALANINE; FLUORESCENT DYES; G(M1) GANGLIOSIDE; GLIOMA; HYBRID CELLS; HYPOXANTHINE; NEUROBLASTOMA; PERTUSSIS TOXIN; RECEPTORS, OPIOID; THYMIDINE; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0030854345     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021993232148     Document Type: Article

References (64)

1. Svennerholm, L. 1963. Chromatographic separation of human brain gangliosides. J. Neurochem. 10:613-623.
2. Yu, R. K., and Saito, M. 1989. Structure and localization of gangliosides. Pages 1-42, in Margolis, R. U., and Margolis, R. K. (eds.), Neurobiology of Glycoconjugates. Plenum, New York.
3. Ledeen, R. W. 1978. Ganglioside structure and distribution: are they localized at the nerve ending? J. Supramol. Struct. 8:1-17.
4. Ledeen, R. W. 1979. Structure and distribution of gangliosides. Pages 1-23, in Margolis, R. U., and Margolis, R. K. (eds.), Complex Carbohydrates of Nervous Tissue. Plenum, New York.
5. Ledeen, R. W., Parsons, S. M., Diebler, M. F., Sbaschnig-Agler, M., and Lazereg, S. 1988. Gangliosides composition of synaptic vesicles from Torpedo electric organ. J. Neurochem. 51:1465-1469.
6. Gillard, B. K., Thurmon, L. T., and Marcus, D. M. 1993. Variable subcellular localization of glycosphingolipids. Glycobiology 3: 57-67.
7. Wu, G., Lu, Z.-H., and Ledeen, R. W. 1995. Induced and spontaneous neuritogenesis are associated with enhanced expression of ganglioside GM1 in the nuclear membrane. J. Neurosci. 15: 3739-3746.
8. 2 from bovine brain. Biochem. J. 299:91-95.
9. Ledeen, R. W., and Wu, G. 1992. Ganglioside function in the neuron. Trends Glycosci. Glycotech. 4:174-187.
10. Hakomori, S.-I., and Igarashi, Y. 1995. Functional role of glycosphingolipids in cell recognition and signaling. J. Biochem. 118: 1091-1103.
11. 1-adrenergic receptor-induced cyclic AMP formation in Sf9 cells. Biochim. Biophys. Acta 1267:1-5.
12. Wu, G., Lu, Z.-H., and Ledeen, R. W. 1996. GM1 ganglioside modulates prostaglandin E1 stimulated adenylyl cyclase in neuro-2A cells. Glycoconjugate J. 13:235-239.
13. Shen, K.-F., Crain, S. M., and Ledeen, R. W. 1991. Brief treatment of sensory neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential. Brain Res. 559:130-138.
14. + currents. J. Neurosci. Res. 42:493-503.
15. Wu, G., Lu, Z.-H., and Ledeen, R.W. 1997. Interaction of δ-opioid receptor with GM1 ganglioside: conversion from inhibitory to excitatory mode. Mol. Brain Res. 44:341-346.
16. Crain, S. M., and Shen, K.-F. 1992. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition. J. Pharmacol. Exp. Ther. 260:182-186.
17. Shen, K.-F., and Crain, S. M. 1989. Dual opioid modulation of the action potential duration of mouse dorsal ganglion neurons in culture. Brain Res. 491:227-242.
18. Crain, S. M., and Shen, K.-F. 1990. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends. Pharmacol. Sci. 11:77-81.
19. Wang, L., and Gintzler, A. R. 1994. Bimodal opioid regulation of cyclic AMP formation: implications for positive and negative coupling of opiate receptors to adenylyl cyclase. J. Neurochem. 63: 1726-1730.
20. Cruciani, R. A., Dvorkin, B., Morris, S. A., Crain, S. M., and Makman, M. H. 1993. Direct coupling of opioid receptor to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc. Natl. Acad. Sci. USA 90:3019-3023.
21. Smart, D., and Lambert, D. G. 1996. The stimulatory effects of opioids and their possible role in the development of tolerance. Trends in Pharmacological Sciences 17:264-269.
22. Johnson, S. M., and Fleming, W. W. 1989. Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. Pharmacol. Rev, 41:435-487.
23. Childers, S. R. 1991. Opioid receptor-coupled second messenger systems. Life Sci. 48:1991-2003.
24. Wu, G., Lu, Z.-H., and Ledeen, R. W. 1995. GM1 conversion of cloned δ-opioid receptor from inhibitor to stimulator of adenylyl cyclase. J. Neurochem. 64 Suppl. S104 (Abstr.)
25. Cannella, M. S., Oderfeld-Nowak, B., Gradkowska, M., Skup, M., Garofalo, L., Cuello, A. C., and Ledeen, R. W. 1990. Derivatives of ganglioside GM1 as neuronotrophic agents: comparison of in vivo and in vitro effects. Brain Res. 513:286-294.
26. Brostrom, C. O., and Kon, C. 1974. An improved protein binding assay for cyclic AMP. Anal. Biochem. 58:459-468.
27. Wu, G., Lu, Z.-H., and Ledeen, R. W. 1991. Correlation of gangliotetraose gangliosides with neunte forming potential of neuroblastoma cells. Devl. Brain Res. 61:217-228.
28. Freedman, S. B., Dawson, G., Villereal, M. L., and Miller R. J. 1984. Identification and characterization of voltage-sensitive calcium channels in neuronal clonal cell lines. J. Neurosci. 4: 1453-1467.
29. Smalheiser, N. R. 1993. Acute neunte retraction elicited by diverse agents is prevented by genistein, a tyrosine kinase inhibitor. J. Neurochem. 61:340-343.
30. s-stimulated adenylyl cyclases. FASEB J. 7:768-775.
31. Chang, K. J., and Cuatrecasas, P. 1979. Multiple opiate receptors: enkephalins and morphine bind to receptors of different specificity. J. Biol. Chem. 254:2610-2618.
32. Sharma, S. K., Nirenberg, M., and Klee, W. A. 1975. Morphine receptors as regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. USA 72:590-594.
33. o, regulates neuronal calcium channels. Nature 325:445-447.
34. Sharma, S. K., Klee, W. A., and Nirenberg, M. 1975. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA 72:3092-3096.
35. Jin, W., Lee, N. M., Loh, H. H., and Thayer, S. A. 1992. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma X glioma hybrid NG108-15 cells. Mol. Pharmacol. 42:1083-1089.
36. Jin, W., Lee, N. M., Loh, H. H., and Thayer, S. A. 1994. Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells. J. Neurosci. 14:1920-1929.
37. Field, A., Gafni, M., Oron, Y., and Sarne, Y. 1995. Multiple effects of opiates on intracellular calcium level and on calcium uptake in three neuronal cell lines. Brain Res. 687:94-102.
38. Same, Y., and Gafni, M. 1996. Determinants of the stimulatory opioid effect on intracellular calcium in SK-N-SH and NG108-15 neuroblastoma. Brain Res. 722:203-206.
39. s-linked opioid receptors. Brain Res. 525:225-231.
40. 3H-norepinephrine release in the human neuroblastoma cell-line SK-N-SH. Brain Res. 656:319-323.
41. 2+/calmodulin- and forskolin-stimulated enzyme activities in rat olfactory bulb. J. Neurochem. 63:161-168.
42. Gintzler, A. R., and Xu, H. 1991. Different G proteins mediate the opioid inhibition or enhancement of evoked [5-methionine] enkephalin release. Proc. Natl. Acad. Sci. USA 88:4741-4745.
43. Huang, L.-Y. M. 1992. The excitatory effect of opioids. Neurochem. Int. 20:463-468.
44. Xu, H., Smolens, I., and Gintzler, A. R. 1989. Opioids can enhance and inhibit the electrically evoked release of methionineenkephalin. Brain Res. 504:36-42.
45. s-linked opioid receptor functions. Brain Res. 531:1-7.
46. Carlson, R. O., Masco, D., Brooker, G., and Spiegel, S. 1994. Endogenous ganglioside GM1 modulates L-type calcium channel activity in N18 neuroblastoma cells. J. Neurosci. 14:2272-2281.
47. Wu, G., Lu, Z.-H., Nakamura, K., Spray, D. C., and Ledeen, R. W. 1996. Trophic effect of cholera toxin B subunit in cultured cerebellar granule neurons: modulation of intracellular calcium by GM1 ganglioside. J. Neurosci. Res. 44:243-254.
48. Milani, D., Minozzi, M. C., Petrelli, L., Guidolin, D., Skaper, S. D., and Spoerri, P. E. 1992. Interaction of ganglioside GM1 with the B subunit of cholera toxin modulates intracellular free calcium in sensory neurons. J. Neurosci. Res. 33:446-475.
49. Wu, G., and Ledeen, R. W. 1991. Stimulation of neunte outgrowth in neuroblastoma cells by neuraminidase: putative role of GM1 ganglioside in differentiation. J. Neurochem. 56:95-104.
50. Wu, G., and Ledeen, R. W. 1994. Gangliosides as modulators of neuronal calcium. Prog. Brain Res. 101:101-112.
51. Guerold, B., Massarelli, R., Forster, V., Freysz, L., and Dreyfus, H. 1992. Exogenous gangliosides modulate calcium fluxes in cultured neuronal cells. J. Neurosci. Res. 32:110-115.
52. Wu, G., Vaswani, K. K., Lu, Z.-H., and Ledeen, R. W. 1990. Gangliosides stimulate calcium flux in Neuro-2A cells and require exogenous calcium for neuritogenesis. J. Neurochem. 55:484-491.
53. Spoerri, P. E., Dozier, A. K., and Roisen, F. J. 1990. Calcium regulation of neuronal differentiation: the role of calcium in GM1-mediated neuritogenesis. Devl. Brain Res. 56:177-188.
54. 2+ signaling pathway by GM1 ganglioside in PC12 cells. J. Biol. Chem. 267:24789-24795.
55. Favaron, M., Manev, H., Alho, H., Bertolino, M., Ferret, B., Guidotti, A., and Costa, E. 1988. Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex. Proc. Natl. Acad. Sci. USA 85:7351-7355.
56. 2+ dynamics after toxic doses of glutamate in cerebellar granule cells. Proc. Natl. Acad. Sci. USA 87:8017-8021.
57. Wu, G., Lu, Z.-H., and Ledeen, R. W. 1995. GM1 ganglioside in the nuclear membrane modulates nuclear calcium homeostasis during neurite outgrowth. J. Neurochem. 64:1419-1422.
58. Scheideler, M. A., and Dawson, G. 1986. Direct demonstration of the activation of UDP-N-acetylgalactosamine: [GM3] N-acetyl-galactosaminyltransferase by cyclic AMP. J. Neurochem. 46: 1639-1643.
59. Crain, S. M., and Shen, K.-F. 1992. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res. 575:13-24.
60. Sabol, S. L., and Nirenberg, M. 1979. Regulation of adenylate cyclase of neuroblastoma X glioma hybrid cells by alpha-adrenergic receptors II, long lived increase of adenylyl cyclase activity mediated by alpha receptors. J. Biol. Chem. 254:1921-1925.
61. Collier, H. O. J. 1984. Cellular aspects of opioid tolerance and dependence. Pages 109-125, in Hughes, J., Collier, H. O. J., Rance, M. J., and Tyres, M. B. (eds.), Opioids: Past, Present and Future. Taylor & Frances Ltd., London.
62. Thomas, J. M., and Hoffman, B. B. 1988. Adenylate cyclase super-sensitivity: A general means of cellular adaptation to inhibitory agonists? Trends Pharmacol. Sci. 8:308-311.
63. Shen, K.-F., and Crain, S. M. 1992. Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid "dependence" without tolerance. Brain Res. 597:74-83.
64. 1 receptor system in neuroblastoma X glioma (NG108-15) hybrid cells. J. Neurochem. 64:2449-2457.